Thousands of non-Muslims evacuated as violence flares in northwest Myanmar

Agencies
August 27, 2017

Yangon/Cox's Bazar, Aug 27: Myanmar's government said it has evacuated at least 4,000 non-Muslim villagers amid ongoing clashes in northwestern Rakhine state, as thousands more Rohingya Muslims sought to flee across the border to Bangladesh on Sunday.

The death toll from the violence that erupted on Friday with coordinated attacks by Rohingya insurgents has climbed to 98, including some 80 insurgents and 12 members of the security forces, the government said.

Fighting involving the military and hundreds of Rohingya across northwestern Rakhine continued on Saturday with the fiercest clashes taking place near the major town of Maungdaw, according to residents and the government.

Bracing for more violence, thousands of Rohingya - mostly women and children - were trying to forge the Naf river separating Myanmar and Bangladesh and the land border. Reuters reporters at the border could hear gunfire from the Myanmar side on Sunday.

Around 2,000 people have been able to cross into Bangladesh since Friday, according to estimates by Rohingya refugees living in the makeshift camps on the Bangladeshi side of the border.

The violence marked a dramatic escalation of a conflict that has simmered in the region since last October, when a similar but much smaller Rohingya attack prompted a brutal military operation beset by allegations of serious human rights abuses.

While the chaos and lack of access made detailed assessments difficult, experts said the latest attacks were so widespread they appeared to be more akin to a movement or an uprising, rather than a regular insurgent offensive.

One army source said the military was also struggling to differentiate.

"All the villagers become insurgents, what they're doing is like a revolution," said the source in Rakhine. "They don't care if they die or not. We can't tell who of them are insurgents."

CHALLENGE FOR SUU KYI

The treatment of approximately 1.1 million Muslim Rohingya in mainly Buddhist Myanmar has emerged as the biggest challenge for national leader Aung San Suu Kyi. Suu Kyi on Friday condemned the raids in which insurgents wielding guns, sticks and homemade bombs assaulted 30 police stations and an army base.

The Nobel Peace Prize laureate has been accused by some Western critics of not speaking out for the long-persecuted Muslim minority.

Win Myat Aye, Myanmar's minister for social welfare, relief and resettlement, told Reuters late on Saturday that 4,000 "ethnic villagers" who had fled their villages had been evacuated, referring to non-Muslim residents of the area.

The ministry is arranging facilities for them in places including Buddhist monasteries, government offices and local police stations in major cities.

"We are providing food to the people cooperating with the state government and local authorities," said Win Myat Aye. He was unable to describe the government's plans to help Rohingya civilians.

Rakhine residents in ethnically mixed or non-Muslim towns have readied knives and sticks to defend themselves. Many were stranded in their villages located in Muslim-majority areas as clashes continued and some roads had been mined, residents said.

People from Maungdaw and another town, Buthidaung, said on Sunday they worried food supply routes had been temporarily cut off.

"Buthidaung will face shortages of food, because no ships have arrived since the fighting started. It is also difficult to send food to the villagers stuck in other areas," Arakan National Party regional lawmaker, Tun Aung Thein, told Reuters by telephone from the town.

"BREAKING POINT"

The Myanmar army operation following attacks last year was heavily criticised internationally amid reports of civilian killings, rape and arson that a United Nations investigation said probably constituted crimes against humanity. Suu Kyi is blocking the U.N.-mandated probe into the allegations.

The Rohingya have for years endured apartheid-like conditions in northwestern Myanmar - they are denied citizenship and face severe restrictions on their movements. Many Myanmar Buddhists regard them as illegal immigrants from Bangladesh.

Observers worry that the latest attacks, across a wider area than October's violence and with many more people involved, represent a "breaking point" many Rohingya reached with the help of a charismatic insurgent leader, Ata Ullah.

Ata Ullah leads the Arakan Rohingya Salvation Army (ARSA) which instigated the October attacks and claimed responsibility for the latest offensive.

Myanmar declared ARSA, previously known as Harakah al-Yaqin, a terrorist organisation in the wake of the attacks.

Across the border, Bangladesh's foreign ministry said it was concerned thousands of "unarmed Myanmar nationals" were planning to enter the country.

Rohingya have been fleeing Myanmar to Bangladesh since the early 1990s and there are now around 400,000 in the country, where they are a source of tension between the two nations who both regard them as the other country's citizens.

The Myanmar army operation following attacks last year was heavily criticised internationally amid reports of civilian killings, rape and arson that a United Nations investigation said probably constituted crimes against humanity. Suu Kyi is blocking the U.N.-mandated probe into the allegations.

The Rohingya have for years endured apartheid-like conditions in northwestern Myanmar - they are denied citizenship and face severe restrictions on their movements. Many Myanmar Buddhists regard them as illegal immigrants from Bangladesh.

Observers worry that the latest attacks, across a wider area than October's violence and with many more people involved, represent a "breaking point" many Rohingya reached with the help of a charismatic insurgent leader, Ata Ullah.

Ata Ullah leads the Arakan Rohingya Salvation Army (ARSA) which instigated the October attacks and claimed responsibility for the latest offensive.

Myanmar declared ARSA, previously known as Harakah al-Yaqin, a terrorist organisation in the wake of the attacks.

Across the border, Bangladesh's foreign ministry said it was concerned thousands of "unarmed Myanmar nationals" were planning to enter the country.

Rohingya have been fleeing Myanmar to Bangladesh since the early 1990s and there are now around 400,000 in the country, where they are a source of tension between the two nations who both regard them as the other country's citizens.

Comments

mark sebastin
 - 
Sunday, 27 Aug 2017

line up everyone and shoot on their head . they are jihadists ....

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 25,2020

Washington, Feb 25: Democratic presidential front-runner Senator Bernie Sanders on Monday slammed President Donald Trump for selling weapons to India, saying that the US should instead partner with New Delhi to fight climate change to save the planet.

Sanders, who has won the Nevada and New Hampshire primaries and tied in Iowa, made the comments after Trump, who is on a two-day visit to India, on Monday announced that the US will sign defence trade deals worth USD 3 billion with India.

In an address at a massive "Namaste Trump" rally at Motera stadium in Ahmedabad, Trump announced that deals to sell state-of-the-art military helicopters and other equipment worth over USD 3 billion will be sealed with India on Tuesday.

“Instead of selling USD 3 billion in weapons to enrich Raytheon, Boeing and Lockheed, the United States should be partnering with India to fight climate change,” Sanders said in a tweet, the first by a Democratic presidential candidate on Trump's India visit.

“We can work together to cut air pollution, create good renewable energy jobs, and save our planet,” he said.

However, a former White House official defended the US' decision to sell arms and weapons to India.

“I'm proud of my service in the White House, in which we poured enormous energy into deepening climate and green tech cooperation w/ India... and also advancing security cooperation and defense sales. I'd like to think both can be part of a strong, values-based partnership,” Joshua White said.

According to the US State Department, India plays a vital role in the US vision for a free and open Indo-Pacific.

In 2016, the US designated India as a Major Defence Partner. Commensurate with this designation, India in 2018 was granted Strategic Trade Authorization tier 1 status, which allows New Delhi to receive license-free access to a wide range of military and dual-use technologies that are regulated by the Department of Commerce.

Bilateral defence trade with India in a little over a decade has increased from near zero in 2008 to USD20 billion.

Among some of the key foreign military sales notified to Congress include MH-60R Seahawk helicopters (USD2.6 billion), Apache helicopters (USD2.3 billion), P-8I maritime patrol aircraft (USD3 billion), and M777 howitzers (USD737 million).

India was the first non-treaty partner to be offered a Missile Technology Control Regime Category-1 Unmanned Aerial System – the Sea Guardian UAS manufactured by General Atomics.

The State Department is also advocating for the Lockheed Martin F-21 and Boeing F/A-18 – two state of the art fighter aircraft that India is currently evaluating.

These platforms provide critical opportunities to enhance India's military capabilities and protect shared security interests in the Indo-Pacific region, it argued.

The top categories of DCS to India include aircraft, electronics and gas turbine engines.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 28,2020

Kuala Lumpur, Jul 28: Malaysia's ex-leader Najib Razak was found guilty Tuesday in his first trial over the multi-billion-dollar 1MDB scandal, two years after the fraud contributed to the downfall of his long-ruling government.

The former prime minister could now face decades in jail after being convicted on all charges in the case related to the looting of sovereign wealth fund 1Malaysia Development Berhad.

Billions of dollars were stolen from the investment vehicle and spent on everything from high-end real estate to pricey art, while investment bank Goldman Sachs also became embroiled in the scandal.

Anger at the looting played a large part in the shock loss of Najib's long-ruling coalition in elections in 2018, and he was arrested and hit with dozens of charges following his defeat.

The verdict was a test of Malaysia's rule of law. It comes about five months after Najib's scandal-plagued party returned to power as part of a coalition, development observers had feared could affect the outcome of the case.

About 16 months after it began, the Kuala Lumpur High Court delivered the verdict in Najib's first trial, which centred on the transfer of 42 million ringgit ($9.9 million) from a former 1MDB unit, SRC International, into his accounts.

Najib had vehemently denied wrongdoing.

But Judge Mohamad Nazlan Mohamad Ghazali took apart all the arguments put forward by his defence, and found him guilty on the seven charges he faced.

"In conclusion, after considering all the evidence in this trial, I find the prosecution has successfully proven the case," the judge told the court.

The charges were one of abuse of power, three of criminal breach of trust and three of money-laundering.

The counts of abuse of power and criminal breach of trust are punishable by up to 20 years in jail each, while the money-laundering charges are punishable by up to 15 years each.

Sentencing was not handed down straight away. The 67-year-old will likely appeal and he may not be sent to jail immediately. If his conviction is upheld, he will also be barred from political office for several years.

Najib had insisted he was ignorant of the transactions.

The defence team portrayed Najib as a victim and instead sought to paint financier Low Taek Jho, a key figure in the scandal who has been charged in the US and Malaysia, as the mastermind.

Low, whose whereabouts are unknown, maintains his innocence.

Prosecutors insisted Najib was in control of the 1MDB unit, SRC International.

The return of Najib's party to power as part of a coalition in March followed the collapse of Mahathir Mohamad's reformist administration.

Since then, 1MDB-linked charges were unexpectedly dropped against the ex-leader's stepson Riza Aziz, a producer of Hollywood movie "The Wolf of Wall Street", in exchange for him agreeing to return assets to Malaysia.

Prosecutors also dropped dozens of charges against Najib ally Musa Aman, the former leader of Sabah state.

The amounts involved in Najib's first case are small compared to those in his second and most significant trial, which centres on allegations he illicitly obtained more than $500 million.

Malaysia had charged Goldman Sachs and some current and former staff, claiming large amounts were stolen when the bank arranged bond issues for 1MDB.

But the two sides agreed to a $3.9 billion settlement last week in exchange for charges being dropped.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 4,2020

Jun 4: A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

Results published Wednesday by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus.

The drug did not seem to cause serious harm, though -- about 40% on it had side effects, mostly mild stomach problems.

 “We were disappointed. We would have liked for this to work,” said the study leader, Dr. David Boulware, an infectious disease specialist at the University of Minnesota.

“But our objective was to answer the question and to conduct a high-quality study,” because the evidence on the drug so far has been inconclusive, he said.

Hydroxychloroquine and a similar drug, chloroquine, have been the subject of much debate since Trump started promoting them in March.

Hydroxychloroquine has long been used for malaria, lupus, and rheumatoid arthritis, but no large studies have shown it or chloroquine to be safe or effective for much sicker patients with coronavirus, and some studies have suggested the drugs may do harm.

Trump took a two-week course of hydroxychloroquine, along with zinc and Vitamin D, after two staffers tested positive for COVID-19, and had no ill effects, according to results of his latest physical released by his doctor Wednesday.

Federal regulators have warned against hydroxychloroquine's use except in hospitals and formal studies because of the risk of side effects, especially heart rhythm problems.

Boulware's study involved 821 people in the United States and Canada living with someone diagnosed with COVID-19 or at high risk of getting it because of their job -- doctors, nurses, ambulance workers who had significant exposure to a sick patient while not wearing full protective gear.

They were randomly assigned to get either the nutrient folate as a placebo or hydroxychloroquine for five days, starting within four days of their exposure. Neither they nor others involved in the research knew who was getting which pills.

After 14 days in the study, 12 per cent on the drug developed COVID-19 symptoms versus 14 per cent in the placebo group, but the difference is so small it could have occurred by chance, Boulware said.

“There's basically no effect. It does not prevent infection,” he said of the drug. Even if it were to give some slim advantage, “we'd want a much larger effect” to justify its use and risk of side effects for preventing illness, he said.

Results were no different among a subgroup of participants who were taking zinc or vitamin C, which some people believe might help make hydroxychloroquine more effective or fight the coronavirus.

There are some big caveats: The study enrolled people through the Internet and social media, relying on them to report their own symptoms rather than having them tracked in a formal way by doctors.

Participants were not all tested for the coronavirus but were diagnosed as COVID-19 cases based on symptoms in many cases. And not all took their medicines as directed.

The results “are more provocative than definitive,” and the drug may yet have prevention benefits if tried sooner or in a different way, Dr. Myron Cohen of the University of North Carolina at Chapel Hill wrote in a commentary in the journal.

Others were glad to see a study that had a comparison group and good scientific methods after so many weaker reports on hydroxychloroquine.

“This fits with everything else we've seen so far which suggests that it's not beneficial," said Dr. Peter Bach, director of a health policy center at Memorial Sloan Kettering Cancer Center in New York.

This study was in younger relatively healthy people, but the results “would make me very discouraged about trying to use this in older people” who are most vulnerable to serious illness from the coronavirus, Bach said.

“If it does work, it doesn't work very well.” Dr. Dan Culver, a lung specialist at the Cleveland Clinic, said there's still a chance that giving the drug sooner than four days after someone's exposure to the virus may help prevent illness.

But the study “takes 'home run' off the table” as far as hopes for the drug, he said.

The study was mostly funded by David Baszucki, founder of Roblox, a California-based game software company, and other private donors and the Minnesota university.

Boulware also is leading a study testing hydroxychloroquine for treating COVID-19. The study is finished and results are being analyzed now.

On Tuesday, the journal Lancet posted an “expression of concern” about a study it published earlier this month of nearly 15,000 COVID-19 patients on the malaria drugs that tied their use to a higher risk of dying in the hospital or developing a heartbeat problem.

Scientists have raised serious questions about the database used for that study, and its authors have launched an independent audit.

That work had a big impact: the World Health Organization suspended use of hydroxychloroquine in a study it is leading, and French officials stopped the drug's use in hospitals. On Wednesday, the WHO said experts who reviewed safety information decided that its study could resume.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.